Los Angeles Capital Management & Equity Research Inc. Trims Holdings in LHC Group, Inc. (LHCG)

Los Angeles Capital Management & Equity Research Inc. reduced its holdings in shares of LHC Group, Inc. (NASDAQ:LHCG) by 27.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,230 shares of the health services provider’s stock after selling 4,256 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in LHC Group were worth $1,054,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in LHCG. BlackRock Inc. increased its stake in shares of LHC Group by 2.7% in the fourth quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock worth $428,687,000 after purchasing an additional 121,385 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of LHC Group by 2.9% in the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after purchasing an additional 20,567 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in shares of LHC Group by 14.0% in the third quarter. Thrivent Financial for Lutherans now owns 486,243 shares of the health services provider’s stock worth $50,078,000 after purchasing an additional 59,816 shares in the last quarter. Rothschild & Co. Asset Management US Inc. increased its stake in shares of LHC Group by 1.2% in the fourth quarter. Rothschild & Co. Asset Management US Inc. now owns 455,678 shares of the health services provider’s stock worth $42,779,000 after purchasing an additional 5,333 shares in the last quarter. Finally, American Century Companies Inc. purchased a new stake in shares of LHC Group in the third quarter worth $35,964,000. 88.57% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ:LHCG opened at $108.12 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61. LHC Group, Inc. has a fifty-two week low of $59.21 and a fifty-two week high of $114.22. The firm has a market cap of $3.39 billion, a P/E ratio of 30.46, a P/E/G ratio of 1.57 and a beta of 0.89.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, February 27th. The health services provider reported $1.03 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.02 by $0.01. LHC Group had a net margin of 3.85% and a return on equity of 8.23%. The firm had revenue of $509.80 million during the quarter, compared to analyst estimates of $522.21 million. During the same quarter in the prior year, the business earned $0.62 earnings per share. LHC Group’s revenue for the quarter was up 75.1% on a year-over-year basis. Research analysts anticipate that LHC Group, Inc. will post 4.2 earnings per share for the current year.

In related news, CEO Keith G. Myers sold 75,000 shares of the company’s stock in a transaction on Friday, February 1st. The shares were sold at an average price of $104.69, for a total transaction of $7,851,750.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Keith G. Myers sold 6,790 shares of the company’s stock in a transaction on Monday, January 7th. The stock was sold at an average price of $95.01, for a total transaction of $645,117.90. Following the transaction, the chief executive officer now owns 155,475 shares of the company’s stock, valued at approximately $14,771,679.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 231,790 shares of company stock valued at $23,766,868. 6.80% of the stock is owned by company insiders.

A number of analysts have recently issued reports on the stock. Robert W. Baird increased their price objective on shares of LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. SunTrust Banks increased their price objective on shares of LHC Group to $130.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Craig Hallum increased their price objective on shares of LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. They noted that the move was a valuation call. BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 28th. Finally, Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $105.00 price objective for the company in a research note on Wednesday, January 2nd. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. LHC Group presently has a consensus rating of “Buy” and a consensus target price of $113.33.

ILLEGAL ACTIVITY WARNING: This piece was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2019/03/11/los-angeles-capital-management-equity-research-inc-trims-holdings-in-lhc-group-inc-lhcg.html.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.

Featured Story: Quick Ratio

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply